A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
about
Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostosesHereditary Multiple Exostoses: a review of clinical appearance and metabolic patternSecondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXTLoss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome.Unsuspected osteochondroma-like outgrowths in the cranial base of Hereditary Multiple Exostoses patients and modeling and treatment with a BMP antagonist in mice.EXTra hit for mouse osteochondroma.Bone Size and Quality Regulation: Concerted Actions of mTOR in Mesenchymal Stromal Cells and OsteoclastsBreakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas familiesHSPG-deficient zebrafish uncovers dental aspect of multiple osteochondromas.No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromasChondrosarcoma: with updates on molecular genetics.Glycobiology and the growth plate: current concepts in multiple hereditary exostosesHeparan sulfate proteoglycans.Primary neoplasms of bones in mice: retrospective study and review of literatureSHP2 regulates chondrocyte terminal differentiation, growth plate architecture and skeletal cell fatesFGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.Heparanase stimulates chondrogenesis and is up-regulated in human ectopic cartilage: a mechanism possibly involved in hereditary multiple exostoses.Rearrangement of chromosome bands 12q14~15 causing HMGA2-SOX5 gene fusion and HMGA2 expression in extraskeletal osteochondromaGenetic mouse models for bone studies--strengths and limitationsThe glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans.Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiencySomatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndromeOsteochondroma of the Hyoid Bone: A Previously Unrecognized Location and Review of the Literature.Mutations in the EXT1 and EXT2 genes in Spanish patients with multiple osteochondromas.Loss of β-catenin induces multifocal periosteal chondroma-like masses in miceNFAT restricts osteochondroma formation from entheseal progenitorsToward an understanding of the short bone phenotype associated with multiple osteochondromas.Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.Inactivation of Fam20B in Joint Cartilage Leads to Chondrosarcoma and Postnatal Ossification Defects.From an orphan disease to a generalized molecular mechanism: PTPN11 loss-of-function mutations in the pathogenesis of metachondromatosisEpiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter.Cell biology of osteochondromas: bone morphogenic protein signalling and heparan sulphates.Hereditary Multiple Exostoses: New Insights into Pathogenesis, Clinical Complications, and Potential Treatments.Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research.Assessing the general population frequency of rare coding variants in the EXT1 and EXT2 genes previously implicated in hereditary multiple exostosesAberrant perichondrial BMP signaling mediates multiple osteochondromagenesis in miceImmunohistochemical Localization of Bone Morphogenetic Proteins (BMPs) and their Receptors in Solitary and Multiple Human OsteochondromasEpiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice.Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference.
P2860
Q27005904-62DD8A22-6B24-429B-92BF-D2B215E2B458Q28067024-E007724C-7389-4B9A-BA61-FB166D09DC6AQ28244569-0FA866B8-6578-4478-9A5A-1EFEA8F90A80Q30475729-B3E28271-1B4A-4E6F-8128-FD1E8675E3B2Q33658041-DBFFEDA3-54AC-48AD-AC0F-C55511F456EFQ33720003-635D4740-054D-49D2-85E1-A6EE3FD36C12Q33794615-99E8E7D8-ADBA-407D-BD24-BF4AE8D0CDCBQ33942525-536825BB-D85D-4B01-8FA6-DC2AAB2553B0Q34130600-FEB73059-8988-44A5-B6B8-AC04AA2E82BBQ34162459-BDC0CAF7-1E28-40C5-A78A-595C479F83C4Q34591289-78674070-B18D-4F13-A968-3CC7F7E23BCCQ35036977-0E9877C0-DF5C-465E-A5CD-0185B0B7EA02Q35059448-D9CCA8FE-56D2-4974-ABA9-D5CE37B28907Q35151483-208973B4-B350-454B-8A9D-BE5BACB10E0BQ35176027-E9FD3694-9EEE-4988-A039-BD2534D23365Q35668685-C5D2C84C-49DB-4939-91A1-DF025E9550E8Q35669031-808631BC-10E5-44AB-88AD-4EFCA35E1FF9Q35805598-66456A53-4F42-456D-B8E5-52A0C449A5EAQ35902980-7D1E41FE-5E4E-4A26-AEF1-2B0DA55B6D31Q35955763-C2D329F9-E084-4A09-BC22-3CA77223318BQ36041855-E5BE80AC-7360-40B6-85E6-573BC32AB2ACQ36190010-AED6F9EA-3EAB-4C25-94F3-5C12C483CC94Q36297145-9E91F375-5EF4-4C4C-938E-600CE0956CAAQ36637045-FAE5667A-CEE8-4FB3-9AD2-CF1421689BCDQ36676500-3A9771E8-D147-46EB-96FA-3F5BBF3A47D5Q36865831-6041F16C-2D22-4637-9A11-C0FFE085F270Q36933108-A5BFEF30-7A99-423B-915C-F7D08EDE45CAQ37069124-CFF3B67B-E399-46FF-953F-BF63B6BB8AFBQ37089677-40B16DD9-9B9A-43F7-9D8A-8944BF965D47Q37590300-9A66E355-49C2-44DE-9216-CC6DE425A6C8Q37940373-0D6DE971-CF9A-403F-9976-9B6149A0CB84Q38114791-63301C80-4625-460B-BDFD-EA83FC433491Q38688265-5E1B9744-205B-4573-B8CA-4020BC30B43EQ39275583-1CF4326B-C90D-4D2A-AC7C-44B0F657EC89Q39402575-DB017097-B541-40FB-8264-763E1D94DBFFQ41252283-2BD53BD4-8A3D-495A-B44D-3EB81222DF01Q41826035-05311C54-848D-471C-B584-BD41979195FEQ41891943-182BB26B-2854-4801-A140-A340DD79989BQ42133421-EE5D7D31-E123-4225-848D-2BED64EE4AFAQ46128938-F8D89164-30E7-42D6-AB08-D950C1681D98
P2860
A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
@ast
A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
@en
type
label
A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
@ast
A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
@en
prefLabel
A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
@ast
A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.
@en
P2093
P2860
P356
P1476
A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes
@en
P2093
Andrea Vortkamp
Baoli Yang
Charles Searby
Florian Grabellus
Gail Kurriger
Jose A Morcuende
Kevin B Jones
Mario R Capecchi
Peter J Roughley
Virginia Piombo
P2860
P304
P356
10.1073/PNAS.0910875107
P577
2009-12-22T00:00:00Z